Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 30 | 0 | 7 | 0 | 129,70 € | 140,87 € | 8,61 % |
| United Therapeutics | 19 | 0 | 4 | 0 | 250,00 € | 287,40 € | 14,96 % |
| Exelixis Inc. | 18 | 0 | 3 | 0 | 18,72 € | 26,01 € | 38,92 % |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | 37,20 € | 84,74 € | 127,81 % |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | 40,40 € | 47,17 € | 16,76 % |
| Repligen Corp. | 13 | 0 | 1 | 0 | 144,45 € | 184,76 € | 27,91 % |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | 22,39 € | 52,03 € | 132,36 % |
| Medpace Holdings Inc | 10 | 0 | 1 | 0 | 364,00 € | 420,62 € | 15,56 % |
| Xencor Inc. | 10 | 1 | 1 | 0 | 21,60 € | 32,58 € | 50,83 % |
| PTC Therapeutics Inc. | 15 | 7 | 3 | 2 | 33,80 € | 41,81 € | 23,71 % |
| Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | 37,00 € | 38,99 € | 5,37 % |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | 93,66 € | - | - |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | 1,47 € | 3,70 € | 151,70 % |
| Novocure Ltd | 1 | 1 | 0 | 0 | 21,36 € | - | - |